Back to Journals » Clinical Ophthalmology » Volume 4

Original Research

Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?

       
Total article views   HTML views PDF downloads Totals
9,622 Dovepress* 9,622+ 2,021 11,643
Totals 9,622 2,021 11,643
*Since 8 April 2010
+Since July 2016

View citations on Google Scholar